JP2006117700A5 - - Google Patents

Download PDF

Info

Publication number
JP2006117700A5
JP2006117700A5 JP2006018081A JP2006018081A JP2006117700A5 JP 2006117700 A5 JP2006117700 A5 JP 2006117700A5 JP 2006018081 A JP2006018081 A JP 2006018081A JP 2006018081 A JP2006018081 A JP 2006018081A JP 2006117700 A5 JP2006117700 A5 JP 2006117700A5
Authority
JP
Japan
Prior art keywords
glycation
composition
protein
skin
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006018081A
Other languages
Japanese (ja)
Other versions
JP4974532B2 (en
JP2006117700A (en
Filing date
Publication date
Priority claimed from FR9916166A external-priority patent/FR2802425B1/en
Application filed filed Critical
Publication of JP2006117700A publication Critical patent/JP2006117700A/en
Publication of JP2006117700A5 publication Critical patent/JP2006117700A5/ja
Application granted granted Critical
Publication of JP4974532B2 publication Critical patent/JP4974532B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Claims (12)

少なくとも１つのヴァシニアム・ミリティラス（Vaccinium myrtillus）種及びヴァシニアム・アングスティフォリウム（Vaccinium angustifollium）種から選択される種の植物の少なくとも１つの抽出物からなる、グリケーションを低減するための薬剤。 An agent for reducing glycation comprising an extract of at least one plant of a species selected from at least one species of Vaccinium myrtillus and Vaccinium angustifollium . グリケーションがタンパク質のグリケーションであることを特徴とする請求項１に記載の薬剤。   The drug according to claim 1, wherein the glycation is protein glycation. タンパク質が、皮膚及び／又は爪及び／又は毛髪のタンパク質であることを特徴とする請求項２に記載の薬剤。   The drug according to claim 2, wherein the protein is skin and / or nail and / or hair protein. 皮膚のタンパク質が真皮のタンパク質であることを特徴とする請求項３に記載の薬剤。   4. The drug according to claim 3, wherein the skin protein is a dermal protein. コラーゲンのグリケーションを低減するための請求項１ないし４の何れか１項に記載の薬剤。   The agent according to any one of claims 1 to 4, which reduces collagen glycation. 爪及び／又は毛髪のタンパク質がケラチンであることを特徴とする請求項３に記載の薬剤。   The nail and / or hair protein is keratin. グリケーションに関連した、皮膚及び／又はその付随構造の加齢の徴候を予防的及び／又は治療的に処置するための、請求項１ないし６の何れか１項に記載の薬剤。   7. Medicament according to any one of claims 1 to 6, for the prophylactic and / or therapeutic treatment of signs of aging of the skin and / or associated structures associated with glycation. 植物がヴァシニアム・ミリティラス（Vaccinium myrtillus）種のものであることを特徴とする請求項１に記載の薬剤。 An agent according to claim 1 which plant is characterized in that it is of Vashiniamu-Miritirasu (Vaccinium myrtillus) species. 請求項１ないし８の何れか１項に記載の薬剤を含有する、グリケーションを低減するための組成物。 The composition for reducing glycation containing the chemical | medical agent of any one of Claim 1 thru | or 8 . 上記薬剤が、組成物の全重量に対して０．００１％〜２５％の範囲の量で存在していることを特徴とする請求項９に記載の組成物。 The composition according to claim 9 , wherein the drug is present in an amount ranging from 0.001% to 25% relative to the total weight of the composition. 上記薬剤が、組成物の全重量に対して０．００５％〜１５％の範囲の量で存在していることを特徴とする請求項１０に記載の組成物。 11. A composition according to claim 10 , characterized in that the medicament is present in an amount ranging from 0.005% to 15% relative to the total weight of the composition. 皮膚及び／又は爪及び／又は毛髪のタンパク質のグリケーションに関連する加齢の徴候を処理する美容処理方法において、有効量の少なくとも１つのヴァシニアム・ミリティラス（Vaccinium myrtillus）種又はヴァシニアム・アングスティフォリウム（Vaccinium angustifollium）種の植物の少なくとも１つの抽出物を含有する化粧品組成物を皮膚及び／又は爪及び／又は毛髪に適用し、該抽出物又は該組成物がグリケーションを阻害するためのものであることを特徴とする方法。 An effective amount of at least one Vaccinium myrtillus species or Vascinium angstifolium in a cosmetic treatment method for treating signs of aging associated with glycation of skin and / or nail and / or hair proteins A cosmetic composition containing at least one extract of a plant of the species (Vaccinium angustifollium) is applied to the skin and / or nails and / or hair, the extract or the composition for inhibiting glycation A method characterized by being.
JP2006018081A 1999-12-21 2006-01-26 Use of at least one cypress plant extract as an anti-glycation agent Expired - Lifetime JP4974532B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR99/16166 1999-12-21
FR9916166A FR2802425B1 (en) 1999-12-21 1999-12-21 USE OF AN EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY AS AN ANTI-GLYCATION AGENT

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001546389A Division JP2004505007A (en) 1999-12-21 2000-12-14 Use of at least one extract of Vaccinium as an anti-glycation agent

Publications (3)

Publication Number Publication Date
JP2006117700A JP2006117700A (en) 2006-05-11
JP2006117700A5 true JP2006117700A5 (en) 2008-02-07
JP4974532B2 JP4974532B2 (en) 2012-07-11

Family

ID=9553560

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001546389A Pending JP2004505007A (en) 1999-12-21 2000-12-14 Use of at least one extract of Vaccinium as an anti-glycation agent
JP2006018081A Expired - Lifetime JP4974532B2 (en) 1999-12-21 2006-01-26 Use of at least one cypress plant extract as an anti-glycation agent

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001546389A Pending JP2004505007A (en) 1999-12-21 2000-12-14 Use of at least one extract of Vaccinium as an anti-glycation agent

Country Status (10)

Country Link
US (1) US7005148B2 (en)
EP (1) EP1242045B1 (en)
JP (2) JP2004505007A (en)
AT (1) ATE339183T1 (en)
AU (1) AU2525401A (en)
CA (1) CA2395283C (en)
DE (1) DE60030766T2 (en)
ES (1) ES2270894T3 (en)
FR (1) FR2802425B1 (en)
WO (1) WO2001045648A2 (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814950B1 (en) * 2000-10-05 2003-08-08 Oreal USE OF AT LEAST ONE EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY, IN COMPOSITIONS FOR TREATING SKIN SIGNS OF AGING
EP1314420A1 (en) * 2001-11-23 2003-05-28 Cognis Iberia, S.L. Anti-ageing composition
FR2862642B1 (en) * 2003-11-20 2006-01-27 Oreal COSMETIC USE OF N-HYDROXY IMIDES
FR2862643B1 (en) * 2003-11-20 2005-12-30 Oreal COSMETIC USE OF N-HYDROXY IMIDES
JP2005306850A (en) * 2004-03-24 2005-11-04 Kose Corp Antidermopathic agent and skin lotion containing the same
FR2871688B1 (en) 2004-06-16 2008-05-16 Oreal METHOD FOR PROMOTING THE PENETRATION OF AN ACTIVE INGREDIENT AND COMPOSITION FOR ITS IMPLEMENTATION
JP2008526956A (en) * 2005-01-11 2008-07-24 セ ヤン チュン COMPOSITION FOR IMPROVING SKIN CONDITION CONTAINING EXTRACT OF BLUE AMBER AND PROCESS FOR PRODUCING THE SAME
FR2883168B1 (en) 2005-03-18 2008-01-11 Oreal COSMETIC CARE COMPOSITIONS, REINFORCING AND / OR REPAIRING KERATIN SUBSTRATES COMPRISING KAP POLYPEPTIDES
US20070048243A1 (en) * 2005-08-30 2007-03-01 L'oreal Anti-aging composition containing criste marine and padina pavonica extracts
FR2902006B1 (en) * 2006-06-13 2009-06-05 Oreal COSMETIC COMPOSITION FOR LIPS ASSOCIATING A SURFACTANT PHOSPHATE AND A SILICONE POLYMER
WO2008110672A1 (en) * 2007-03-12 2008-09-18 L'oreal Use of a c-glycoside derivative as an anti-oxidant agent
FR2918269B1 (en) 2007-07-06 2016-11-25 Oreal SOLAR PROTECTION COMPOSITION CONTAINING THE ASSOCIATION OF SEMI-CRYSTALLINE POLYMER AND HOLLOW LATEX PARTICLES
FR2918561B1 (en) 2007-07-09 2009-10-09 Oreal USE FOR COLORING THE SKIN OF DEHYDROASCORBIC ACID OR POLYMERIC DERIVATIVES; METHODS OF CARE AND / OR MAKE-UP.
FR2918569B1 (en) * 2007-07-09 2012-09-28 Engelhard Lyon SUBSTANCES INHIBITING GLYCATION OF PROTEINS.
FR2918563B1 (en) 2007-07-12 2009-12-04 Oreal AQUEOUS FLUID PHOTOPROTECTIVE COMPOSITION BASED ON A POLYAMIDE POLYMER WITH TERTIARY AMIDE TERMINATION.
FR2918883B1 (en) 2007-07-17 2010-01-15 Oreal USE OF A CULTIVE BACTERIAL EXTRACT ON THERMAL WATER FOR THE TREATMENT OF DRY SKINS
JP5362326B2 (en) * 2008-02-01 2013-12-11 株式会社ファンケル MIF secretion inhibitor
FR2930154B1 (en) * 2008-04-21 2012-04-20 Oreal USE OF A BAY EXTRACT, AND ESPECIALLY OF WOLFBERRY, TO MAINTAIN AND / OR RESTORE THE TONICITY AND / OR FERTILIZATION OF THE SKIN
FR2931064B1 (en) 2008-05-14 2010-08-13 Oreal COSMETIC COMPOSITION CONTAINING A DIBENZOYLMETHANE DERIVATIVE AND A PYRROLIDINONE DERIVATIVE; METHOD FOR PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE DERIVATIVE
FR2936706B1 (en) 2008-10-08 2010-12-17 Oreal COSMETIC COMPOSITION CONTAINING A DIBENZOYLMETHANE DERIVATIVE AND A DITHIOLANE COMPOUND; METHOD FOR PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE DERIVATIVE
FR2939036B1 (en) 2008-12-01 2010-12-17 Oreal METHOD OF ARTIFICIAL COLORING OF THE SKIN USING A MIXTURE OF CAROTENOID AND LIDOPHILE GREEN COLOR NEW MIXTURE OF LIPOPHILIC COLORANTS; COMPOSITION
FR2940608B1 (en) 2008-12-30 2011-04-22 Oreal USE OF MONOSACCHARIDES AND COMPOSITION
FR2940612B1 (en) 2008-12-30 2011-05-06 Oreal ASSOCIATION OF MONOSACCHARIDES WITH ASCORBIC ACID AND ITS USE IN COSMETICS
FR2940615B1 (en) 2008-12-30 2011-12-30 Oreal ASSOCIATION OF MONOSACCHARIDES WITH ANTIOXIDANT AGENTS AND ITS USE IN COSMETICS
FR2940613B1 (en) 2008-12-30 2012-09-21 Oreal ASSOCIATION OF MONOSACCHARIDES WITH SOLAR FILTERS AND ITS USE IN COSMETICS
FR2940609B1 (en) 2008-12-30 2011-05-06 Oreal ASSOCIATION OF MONOSACCHARIDES AND DESQUAMANT AGENTS AND USE THEREOF IN COSMETICS
FR2940610B1 (en) 2008-12-30 2011-05-06 Oreal ASSOCIATION OF MONOSACCHARIDES WITH C-GLYCOSIDE DERIVATIVES AND ITS USE IN COSMETICS
FR2940611B1 (en) 2008-12-30 2012-01-13 Oreal ASSOCIATION OF MONOSACCHARIDES AND ADENOSINE AND ITS USE IN COSMETICS
WO2011073576A2 (en) 2009-12-18 2011-06-23 L'oreal Skin-colouring method using a compound that can be condensed in situ and a skin-colouring agent
US9615747B2 (en) * 2010-01-19 2017-04-11 Access Business Group International Llc Method for determining skin glycation
KR101176275B1 (en) 2010-01-25 2012-08-22 정만영 Composition for Treating Atopic Dermatitis Comprising Extract from Vaccinium Uliginosum as an Active Ingredient
FR2960773B1 (en) 2010-06-03 2015-12-11 Oreal COSMETIC PROCESSING METHODS USING A POLYAMIDE-POLYETHER POLYMER-BASED COATING
WO2012038879A2 (en) 2010-09-20 2012-03-29 L'oreal Aqueous cosmetic composition comprising alkylcellulose
DE202011110588U1 (en) 2010-09-20 2015-02-05 L'oréal Alkylcellulose-containing aqueous cosmetic composition
FR2967350B1 (en) 2010-11-15 2015-05-01 Oreal SOLID COSMETIC COMPOSITION IN THE FORM OF COMPACT POWDER
FR2967348B1 (en) 2010-11-17 2013-05-10 Oreal COSMETIC COMPOSITION FOR EYE CONTOUR
JP5905258B2 (en) * 2011-07-01 2016-04-20 株式会社 資生堂 Platelet-derived growth factor-BB production enhancer, mesenchymal stem cell production promoter containing the same, stem cell stabilizer, and dermal regeneration agent
FR2979540B1 (en) 2011-09-06 2013-12-27 Oreal ASSOCIATION OF CARRAGENAN AND C-GLYCOSIDE AND USES THEREOF
FR2985175B1 (en) 2012-01-02 2015-11-06 Oreal AQUEOUS COSMETIC COMPOSITION COMPRISING ALKYLCELLULOSE, NON-VOLATILE OILS, AT LEAST ONE WAX AND AT LEAST ONE GEMINE SURFACTANT
FR2985180B1 (en) 2012-01-02 2020-06-19 L'oreal WATER-IN-OIL EMULSION COMPRISING ALKYLCELLULOSE, NON-VOLATILE OILS, AND AT LEAST ONE SURFACTANT
FR2985174B1 (en) 2012-01-02 2014-03-07 Oreal AQUEOUS COSMETIC COMPOSITION COMPRISING ALKYLCELLULOSE, NON-VOLATILE OILS, AT LEAST ONE WAX AND AT LEAST ONE PARTICULAR HYDROPHILIC GELIFIER
FR2985176B1 (en) 2012-01-02 2015-05-29 Oreal AQUEOUS LIQUID COSMETIC COMPOSITION COMPRISING ALKYLCELLULOSE, NON-VOLATILE OILS AND AT LEAST ONE SURFACTANT
FR2985178B1 (en) 2012-01-02 2014-01-31 Oreal AQUEOUS COSMETIC COMPOSITION COMPRISING ALKYLCELLULOSE, NON-VOLATILE OILS, A PARTICULAR WAX AND A SURFACTANT
US20150104399A1 (en) * 2012-05-14 2015-04-16 Biocogent, Llc Prevention of fibroblast collapse
FR2992644B1 (en) 2012-07-02 2015-07-03 Exsymol Sa FAMILY OF POLYAMINE ARYLETHYLAMIDE COMPOUNDS, AND THEIR COSMETIC OR DERMOCOSMETIC APPLICATIONS
FR2996133B1 (en) 2012-10-02 2015-06-26 Oreal NOVEL COSMETIC USES OF DISPERSING POLYMERS IN ASSOCIATION WITH AT LEAST ONE ACTIVE
WO2014097258A2 (en) 2012-12-20 2014-06-26 L'oreal Aqueous cosmetic composition comprising alkylcellulose
JP2016074690A (en) * 2015-11-16 2016-05-12 株式会社 資生堂 Platelet derived growth factor-bb production enhancer, as well as mesenchymal stem cell production promoter, stem cell stabilizer, and dermis regeneration agent containing the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2159053B (en) * 1984-05-22 1987-11-04 Phyllis Menzies Hair lotions
JPS63145235A (en) * 1986-12-10 1988-06-17 Nikko Kemikaruzu Kk External drug for skin
FR2612775B1 (en) * 1987-03-25 1991-10-11 Thorel Jean COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SKIN DEGENERATION
BE1004405A3 (en) * 1990-07-02 1992-11-17 Raquet Jean Paul Manufacturing method body care products.
IL103101A (en) * 1992-09-08 1997-03-18 Albert Metsada Topical composition for rejuvenating skin
JP3502415B2 (en) * 1993-05-28 2004-03-02 株式会社コーセー Maillard reaction inhibitor
JPH07324025A (en) * 1994-05-31 1995-12-12 Sankoudou:Kk External agent for suppressing maillard reaction
JP3495446B2 (en) * 1995-02-24 2004-02-09 花王株式会社 Hair cosmetics
FR2736263B1 (en) * 1995-07-07 1997-09-26 C3D Sarl DEPIGMENTING DERMOCOSMETIC COMPOSITION AND ITS USE
FR2744366B1 (en) * 1996-02-06 1998-03-27 Serobiologiques Lab Sa USE OF EXTRACTS FROM UVA URSI PLANT AND / OR LESPEDEZA CAPITATA PLANT AND COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH EXTRACTS
JP3872834B2 (en) * 1996-03-04 2007-01-24 第一製薬株式会社 Maillard reaction inhibitor
WO1998005294A1 (en) * 1996-08-02 1998-02-12 Plum Kemi Produktion A/S An oil-in-water emulsion for use on human skin for cleansing, preserving or improving the condition of the skin
BE1011151A3 (en) * 1997-05-13 1999-05-04 Jose Remacle Use of a pharmaceutical composition for treating and / or preventing ischemia.
EP0914816A4 (en) * 1997-05-19 2000-08-23 Shiseido Co Ltd Scalp care compositions
FR2774366A1 (en) 1998-02-02 1999-08-06 Felix Bismuth Device for joining two containers to produce physical training article
JP3040992B2 (en) * 1998-06-11 2000-05-15 株式会社ファンケル Food composition
JP2000256176A (en) * 1999-03-02 2000-09-19 Shalom:Kk Skin cosmetic

Similar Documents

Publication Publication Date Title
JP2006117700A5 (en)
JP2004505007A5 (en)
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
WO2009101503A3 (en) Use of natural active substances in cosmetic or therapeutic compositions
IL219239A0 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
EA200970853A1 (en) COMPOSITIONS FOR PERSONAL HYGIENE WITH IMPROVED Flavor Delivery
WO2010101742A3 (en) Ampholytic ter-polymers for use in personal care compositions
NZ593771A (en) Cyclosporine compositions for enhancing nail growth
NO20045521L (en) Diarylurea derivatives useful for the treatment of protein kinase-dependent diseases
ES2330291B1 (en) USEFUL PEPTIDES IN THE TREATMENT OF SKIN, MUCOSAS AND / OR LEATHER HAIR AND ITS USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS.
BRPI0700678A (en) method for improving sleep behaviors
DK1962815T3 (en) Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches containing said polymers
WO2015031971A3 (en) A composition comprising guacatonga extract and aroeira extract, use thereof for preventing and/or treating skin ageing
WO2015056216A3 (en) Peptide composition and uses thereof
AR072476A1 (en) A METHOD TO REDUCE TRANSPIRATION IN THE AXILA. COSMETIC COMPOSITION. USE.
ES2161888T3 (en) USE OF LAMINARINE AND OLIGOSACARIDS DERIVED FROM LAMINARINE IN COSMETOLOGY AND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR SKIN TREATMENT.
WO2002064088A3 (en) Pharmaceutical composition for the treatment of alopecia
EP2308837A3 (en) Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
WO2009106715A3 (en) Peptide derived from a protein of the aquaporin family
WO2010117709A3 (en) Peptide-based systems for delivery of costmetic agents
WO2008145849A3 (en) Pharmaceutical and/or cosmetic composition containing aconitase-activating active ingredients
DE602006005637D1 (en) ENTPIGMENTIZING BZW. CREAMING COSMETICS COMPOSITION CONTAINING AT LEAST ONE OXAZOLINE AS AN ACTIVE SUBSTANCE
WO2008078050A3 (en) Use of at least one mono-unsaturated fatty acid for the treatment of fragile skin, mucous or semi-mucous tissues and scalp
DE602004029993D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRUG INDEPENDENCE
WO2008145850A3 (en) Use of an active ingredient derived from amaranth (amaranthus hypochondriacus) for preparing a composition for protecting mitochondria